Gary J Doherty - Department of Oncology, Cambridge University Hospitals NHS Foundation Trust

基本信息

浏览量：18

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 57 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Differential Safety Profiles of Durvalumab Monotherapy and Durvalumab in Combination with Tremelimumab in Adult Patients with Advanced Cancers

Claire Morgan, John Kurland, Mayur Patel, Cathy O'Brien, Pamela Concepcion,Gary J Doherty, Stephan Hois,Alejandra Negro, Dejan Pavlovic, Karen A Robbins

Journal for immunotherapy of cancerno. 5 (2025)

引用0浏览0WOS引用

Machine Learning Modeling of Patient Health Signals Informs Long-Term Survival on Immune Checkpoint Inhibitor Therapy

Gerald J. Sun,Gustavo Arango-Argoty,Gary J. Doherty, Damian E. Bikiel, Dejan Pavlovic, Allen C. Chen,Ross A. Stewart,Zhongwu Lai,Etai Jacob

iScienceno. 9 (2024): 110634-110634

引用1浏览0WOS引用

Outcomes with Perioperative Durvalumab (D) in Pts with Resectable NSCLC and Baseline N2 Lymph Node Involvement (N2 R-NSCLC): an Exploratory Subgroup Analysis of AEGEAN

John Heymach,Martin Reck,Tetsuya Mitsudomi,Janis M. Taube,Alexander I. Spira,Jamie E. Chaft,Gary J. Doherty,Helen Mann,Tamer M. Fouad,David H. Harpole

Journal of Clinical Oncologyno. 16_suppl (2024): 8011-8011

引用0浏览0引用

BMScope: A Scoping Review to Chart the Evolving Clinical Study Landscape in Brain and Leptomeningeal Metastasis

R. Heywood, V Cheng,R. Zakaria,R. Burger,K. Zucker, S. Kannan, M. Putra,A. Fitzpatrick,G. Doherty,P. Sanghera,M. Jenkinson,C. Palmieri

NEURO-ONCOLOGY (2024): V87-V87

引用0浏览0WOS引用

Abstract CT238: Associations of Ctdna Levels During Neoadjuvant Treatment with Pathological Response in Patients with Resectable NSCLC from the Phase 3 AEGEAN Trial

Davina Gale,Zhou Zhu,Zhongwu Lai,Martin Reck,David H. Harpole,Janis M. Taube,Tetsuya Mitsudomi,Maximilian J. Hochmair,Thomas Winder,László Urbán,Jerónimo Rafael Rodríguez‐Cid,Quincy Chu,Jamie E. Chaft,Ross Stewart,Darren Hodgson,Gary J. Doherty,John V. Heymach

Cancer Researchno. 7_Supplement (2024): CT238-CT238

引用0浏览0引用

Implementing Circulating Tumor DNA As a Prognostic Biomarker in Resectable Non-Small Cell Lung Cancer

Chris Abbosh,Darren Hodgson,Gary J. Doherty,Davina Gale,James R.M. Black,Leora Horn,Jorge S. Reis-Filho,Charles Swanton

Trends in cancerno. 7 (2024): 643-654

引用4浏览0WOS引用

Ctdna Dynamics and Neoadjuvant Treatment Responses in Patients with Resectable NSCLC from the Phase 3 AEGEAN Trial

Christian Schumann,John V. Heymach,David Harpole,Testuya Mitsudomi,Janis M. Taube,Gabriella Galffy,Maximilian Hochmair,Thomas Winder,Ruslan Zukov, Gabriel Garbaos,Shugeng Gao,Hiroaki Kuroda,Jian You,Kang-Yun Lee,Lorenzo Antonuzzo, Mike Aperghis,Gary J. Doherty,Helen Mann,Tamer M. Fouad,Martin Reck, Silvan Becker

ONCOLOGY RESEARCH AND TREATMENT (2024): 126-127

引用0浏览0引用

Abstract CT005: AEGEAN: A Phase 3 Trial of Neoadjuvant Durvalumab + Chemotherapy Followed by Adjuvant Durvalumab in Patients with Resectable NSCLC

John V. Heymach,David Harpole,Tetsuya Mitsudomi, Janis M. Taube,Gabriella Galffy,Maximilian Hochmair,Thomas Winder,Ruslan Zukov, Gabriel Garbaos,Shugeng Gao,Hiroaki Kuroda,Jian You,Kang-Yun Lee, Lorenzo Antonuzzo, Mike Aperghis,Gary J. Doherty,Helen Mann,Tamer M. Fouad,Martin Reck

Cancer Researchno. 8_Supplement (2023)

引用42浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn